Novelion Therapeutics Inc - Strategy, SWOT and Corporate Finance Report

Novelion Therapeutics Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Novelion Therapeutics Inc (Novelion), formerly QLT Inc, is a biopharmaceutical company that focuses on the development and commercialization of products and solutions for the treatment of people living with rare diseases. The company's two marketed products are Lomitapide, a small molecule microsomal triglyceride transfer protein inhibitor offered under the brand name JUXTAPID, and Metreleptin, a recombinant analog of human leptin offered under the brand name MYALEPT. It also possesses another product candidate, zuretinol acetate, an oral synthetic retenoid for use in treatment of inherited retinal disease. The company operates along with its subsidiaries across North America, South America, Europe and Asia. Novelion is headquartered in Vancouver, British Columbia, Canada.

Scope

  • Detailed information on Novelion Therapeutics Inc required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Novelion Therapeutics Inc in the form of a SWOT analysis
  • An in-depth view of the business model of Novelion Therapeutics Inc including a breakdown and examination of key business segments
  • News about Novelion Therapeutics Inc, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

  • Gain understanding of Novelion Therapeutics Inc and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Novelion Therapeutics Inc as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Novelion Therapeutics Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Regeneron Pharmaceuticals Inc

Mimetogen Pharmaceuticals Inc

Genentech Inc

ASKA Research

Regeneron Pharmaceuticals Inc

Mimetogen Pharmaceuticals Inc

Genentech Inc

ASKA Research

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1 - About the Company 6

Novelion Therapeutics Inc ...

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1 - About the Company 6

Novelion Therapeutics Inc - Key Facts 6

Novelion Therapeutics Inc - Key Employees 7

Novelion Therapeutics Inc - Key Employee Biographies 8

Novelion Therapeutics Inc - Major Products and Services 9

Novelion Therapeutics Inc - History 10

Novelion Therapeutics Inc - Company Statement 12

Novelion Therapeutics Inc - Locations And Subsidiaries 14

Head Office 14

Other Locations & Subsidiaries 14

Section 2 – Company Analysis 16

Company Overview 16

Novelion Therapeutics Inc - Business Description 17

Product Category: Lomitapide 17

Overview 17

Performance 17

Product Category: Metreleptin 17

Overview 17

Performance 18

Geographical Segment: Brazil 18

Performance 18

Geographical Segment: Other Foreign countries 18

Performance 18

Geographical Segment: The US 18

Performance 18

R&D Overview 18

Novelion Therapeutics Inc - SWOT Analysis 19

SWOT Analysis - Overview 19

Novelion Therapeutics Inc - Strengths 19

Novelion Therapeutics Inc - Weaknesses 20

Novelion Therapeutics Inc - Opportunities 21

Novelion Therapeutics Inc - Threats 22

Novelion Therapeutics Inc - Key Competitors 23

Section 3 – Company Financial Ratios 24

Financial Ratios - Capital Market Ratios 24

Financial Ratios - Annual Ratios 25

Performance Chart 28

Financial Performance 28

Financial Ratios - Interim Ratios 29

Financial Ratios - Ratio Charts 30

Section 4 – Company’s Lifesciences Financial Deals and Alliances 31

Novelion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31

Novelion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 32

Novelion Therapeutics Inc, Recent Deals Summary 33

Section 5 – Company’s Recent Developments 34

May 10, 2018: Novelion Therapeutics Reports First Quarter 2018 Financial Results 34

Feb 28, 2018: Novelion Therapeutics Observes Rare Disease Day 35

Jan 30, 2018: Novelion Therapeutics Announces Sentencing of Subsidiary Aegerion Pharmaceuticals 36

Jan 24, 2018: Novelion Therapeutics Announces Cost Reduction Plans and Capital Structure Review 37

Dec 04, 2017: Novelion Therapeutics Appoints Michael Price as Senior Vice President and Chief Financial Officer 38

Nov 21, 2017: Novelion Therapeutics Provides Update on Agreement between Aegerion Pharmaceuticals and U.S. Department of Justice 39

Nov 09, 2017: Novelion Therapeutics Reports Third Quarter 2017 Financial Results and Announces Leadership Change 40

Oct 31, 2017: Novelion Therapeutics Expands Leadership Team with Appointment of Jeffrey Hackman as Chief Operating Officer 42

Oct 12, 2017: Novelion Therapeutics Strengthens Leadership Team with Appointment of Murray Stewart, M.D., as Executive Vice President, Head of R&D 43

Sep 11, 2017: Novelion Therapeutics Appoints Suzanne Bruhn, Ph.D. to Board of Directors 44

Section 6 – Appendix 45

Methodology 45

Ratio Definitions 45

About GlobalData 49

Contact Us 49

Disclaimer 49

List of Tables

List of Tables

Novelion Therapeutics Inc, Key Facts 6

Novelion Therapeutics Inc, Key Employees 7

Novelion Therapeutics Inc, Key Employee Biographies 8

Novelion Therapeutics Inc, ...

List of Tables

Novelion Therapeutics Inc, Key Facts 6

Novelion Therapeutics Inc, Key Employees 7

Novelion Therapeutics Inc, Key Employee Biographies 8

Novelion Therapeutics Inc, Major Products and Services 9

Novelion Therapeutics Inc, History 10

Novelion Therapeutics Inc, Other Locations 14

Novelion Therapeutics Inc, Subsidiaries 14

Novelion Therapeutics Inc, Key Competitors 23

Novelion Therapeutics Inc, Ratios based on current share price 24

Novelion Therapeutics Inc, Annual Ratios 25

Novelion Therapeutics Inc, Annual Ratios (Cont...1) 26

Novelion Therapeutics Inc, Annual Ratios (Cont...2) 27

Novelion Therapeutics Inc, Interim Ratios 29

Novelion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31

Novelion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 32

Novelion Therapeutics Inc, Recent Deals Summary 33

Currency Codes 45

Capital Market Ratios 45

Equity Ratios 46

Profitability Ratios 46

Cost Ratios 47

Liquidity Ratios 47

Leverage Ratios 48

Efficiency Ratios 48

List of Figures

List of Figures

Novelion Therapeutics Inc, Performance Chart (2013 - 2017) 28

Novelion Therapeutics Inc, Ratio Charts 30

Novelion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals ...

List of Figures

Novelion Therapeutics Inc, Performance Chart (2013 - 2017) 28

Novelion Therapeutics Inc, Ratio Charts 30

Novelion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31

Novelion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 32

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports